Issue 61 July - August 2014

Keeping one step ahead: Could trials do more for patients with incurable cancer?

Joining a clinical trial can be a lifeline for patients with few options open to them. But are outdated attitudes and practices preventing them from benefiting as much as they could?

Read More ...
Issue 61 July - August 2014

Marcel Verheij: Revolutionising radiotherapy

Could intelligent combinations of drugs and radiation take precision radiotherapy to new levels? Marcel Verheij believes so, but may struggle to prove it without a fairer share of funding

Read More ...
Issue 61 July - August 2014

Change must come from within

Is progress against cancer is being stifled because young researchers are obliged to spend their best years competing for grants within a system biased against innovation?

Read More ...
Issue 60 May - June 2014

How Europe can develop better, cheaper cancer drugs

Modern tools of biological investigation give us opportunities to develop drugs much more efficiently. The president of Europe’s most important trials organisation explains how these opportunities can – and must – be exploited to start delivering drugs that are more effective and more affordable.

Read More ...
Issue 60 May - June 2014

Top trials group turns its attention survivors

EORTC boosts efforts to address the long-term problems faced by people who have been treated for cancer.

Read More ...